Verisign Inc. stock edges lower as CEO share sale and analyst target hikes frame valuation debate

Published on 09/17/2026 at 20:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Verisign Inc. stock traded around USD 298.46 on September 17, 2026, just 4.5 percent below its 52-week high as CEO D. James Bidzos sold USD 978,712 in shares. Analysts recently lifted fair value estimates and raised price targets, sharpening the focus on domain growth and legal risks.

Flatlay mit Aktienzertifikat, ISIN-Karte, Glasfaserkabel und Router — Verisign Inc. (US92343E1029) Aktie symbolisiert durch Zertifikat, ISIN-Karte und Glasfaserkabel im Flatlay-Arrangement, Illustration mit AI erstellt.

Verisign Inc. stock (ISIN US92343E1029) traded near USD 298.46 on Nasdaq on September 17, 2026, leaving the shares roughly 4.5 percent below a 52-week high of USD 312.48 and close to levels highlighted in recent insider trading disclosures. As of the afternoon session on September 17, 2026, the stock was quoted around USD 297.54, down about 0.3 percent from the opening level of USD 297.48 according to Nasdaq data cited in a German market report.

CEO share sale puts insider activity in focus

Insider dealing has given investors a concrete new datapoint this week. According to Investing.com on September 17, 2026, Executive Chairman, President and CEO D. James Bidzos sold 3,300 shares of Verisign common stock on September 15, 2026 for total proceeds of approximately USD 978,712. The filing shows weighted average sale prices between USD 295.26 and USD 298.68, with individual trades ranging from about USD 294.56 up to USD 298.93, indicating that the transactions were executed very close to the current market range.

The same insider report notes that following these trades Bidzos still holds a substantial direct position in Verisign, with his remaining stake reported at more than 388,000 shares, underscoring that the sale represents only a small fraction of his total exposure to the company. As Investing.com France highlights, the timing of the sale is notable because the stock price at USD 298.46 is only 4.5 percent below the 52-week high of USD 312.48, putting the CEO trades near the top of the recent range and focusing attention on valuation at these levels.

Analysts lift fair value and price targets on domain growth expectations

Alongside the insider activity, several analysts have updated their view on Verisign over the past days. An overview on Simply Wall St updated on September 17, 2026 reports that a group of seven analysts has lifted their fair value estimate for Verisign to USD 285 per share, up from a previous level of USD 265. That 7.55 percent increase in fair value reflects expectations for stronger domain-related growth into 2027 and recent changes in .net wholesale pricing, even though the shares are currently trading slightly above that intrinsic estimate.

Within the same update, Simply Wall St notes that JPMorgan has raised its price target on Verisign stock to USD 316 from USD 308 while maintaining a Neutral rating. The new JPMorgan target represents a roughly 2.6 percent increase from the prior target and implies modest upside of about 6 percent from the current market level near USD 298.46, suggesting that while the bank sees some appreciation potential, it does not yet view the shares as compellingly undervalued given existing regulatory and competitive risks.

Data compiled by Yahoo Finance on September 17, 2026 shows an average analyst price target of approximately USD 321.40 for Verisign, with a low target of USD 270 and a high target of USD 355. With the shares at around USD 298.45 at the time of that snapshot, the consensus implies upside of roughly 7.7 percent to the average target and more substantial potential if the stock were to approach the high end of the range, while still leaving room for downside to the more cautious low estimate.

Recent quarterly results show mixed picture

Fundamentals from the latest reported quarter provide additional context for these valuation debates. According to the coverage by Investing.com France, Verisign reported its financial results for the second quarter of 2026 (Q2 2026) with earnings per share of USD 2.38. This figure came in below the analyst consensus expectation of USD 2.45, marking an earnings shortfall of USD 0.07 per share for the quarter and highlighting the sensitivity of the business to incremental changes in domain pricing and volume.

The same Q2 2026 report shows that revenue reached USD 434.6 million, slightly ahead of the consensus forecast of USD 433.83 million. That represents an outperformance of USD 0.77 million, or about 0.2 percent, compared with expectations, indicating that while topline growth was modest it did exceed the Street view even as margin pressures led to the earnings miss. For investors, the combination of a small revenue beat and a small EPS miss in Q2 2026 underscores that Verisign remains a high-margin, cash-generative business but that incremental regulatory or competitive changes can quickly affect profitability.

Looking ahead, analysts cited by finanzen.ch expect Verisign to earn about USD 9.79 per share for the full year 2026. If the current share price around USD 298 is used as a reference, that full-year EPS estimate implies a forward price-earnings multiple close to 30.4, a level that many investors would classify as demanding for a mature infrastructure provider and which reinforces the view from several valuation models that the stock trades at a premium to intrinsic value.

Legal and regulatory risks remain on the radar

Beyond earnings, legal developments are an important part of the story. The Simply Wall St update points out that on September 4, 2026 a class action lawsuit was filed in the U.S. District Court for the Central District of California accusing Verisign and the domain regulator ICANN of maintaining an illegal monopoly in .com domains and charging excessive wholesale fees. As Simply Wall St describes, this lawsuit directly challenges the company’s long-standing business model in .com domains and could, over time, affect permitted pricing or contractual terms, even though any resolution is likely to take years.

For investors, the combination of a high forward valuation multiple, recent insider selling near the top of the range and a pending class action lawsuit presents a nuanced risk-reward picture. On the positive side, analysts still expect steady demand for domain registrations and renewals and have raised fair value and price targets based on domain growth expectations, but regulatory and legal headwinds could limit how much of that anticipated growth ultimately translates into shareholder returns if constraints on pricing or additional oversight emerge.

Stock trades near recent highs ahead of next earnings date

From a trading perspective, recent price action has been active but contained within a relatively narrow band. A report from finanzen.ch on September 17, 2026 notes that by 16:28 local time the shares had slipped about 0.3 percent in Nasdaq trading to USD 297.54, after opening at USD 297.48 and touching an intraday low of USD 295.33. A separate update from the same portal on September 16, 2026 recorded the stock up about 1.3 percent at USD 301.22 by 20:26, with the session’s high at USD 301.51 and a start-of-trading level of USD 295.89, showing that the shares have oscillated within a roughly USD 295 to USD 301 corridor over the past two sessions.

Looking further ahead, finanzen.ch also reports that Verisign has scheduled the release of its Q3 2026 financial results for October 22, 2026. That next earnings date is a key checkpoint for shareholders, as it will show whether the company can build on the slight revenue outperformance and address the EPS shortfall seen in Q2 2026, and whether the legal and regulatory backdrop has evolved in ways that may influence guidance.

As of the latest available data on September 17, 2026, Verisign Inc. stock is trading on Nasdaq under the ticker VRSN, with the USD 297.54 price level sitting only a few percent below the 52-week high of USD 312.48 and significantly above the current fair value estimate of USD 285 published by Simply Wall St. For investors, the upcoming Q3 2026 report and the progress of the class action lawsuit will likely be decisive in determining whether the stock can sustain its premium valuation or whether the market starts to re-rate the shares toward the fair value range suggested by analysts and valuation models.